U.S. flag

An official website of the United States government

NC_000017.11:g.(?_15239461)_(15260737_?)del AND Charcot-Marie-Tooth disease, type I

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 4, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000813337.3

Allele description [Variation Report for NC_000017.11:g.(?_15239461)_(15260737_?)del]

NC_000017.11:g.(?_15239461)_(15260737_?)del

Genes:
MIR4731:microRNA 4731 [Gene - HGNC]
PMP22:peripheral myelin protein 22 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17p12
Genomic location:
Preferred name:
NC_000017.11:g.(?_15239461)_(15260737_?)del
HGVS:
  • NC_000017.11:g.(?_15239461)_(15260737_?)del
  • NC_000017.10:g.(?_15142778)_(15164054_?)del

Condition(s)

Name:
Charcot-Marie-Tooth disease, type I (CMT1)
Synonyms:
Charcot-Marie-Tooth, Type 1; Charcot-Marie-Tooth disease type 1
Identifiers:
MONDO: MONDO:0019011; MedGen: C0751036

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000953695Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 4, 2018)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Deletion of the PMP22 gene and hereditary neuropathy with liability to pressure palsies.

Pareyson D, Taroni F.

Curr Opin Neurol. 1996 Oct;9(5):348-54. Review.

PubMed [citation]
PMID:
8894410

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000953695.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

A gross deletion of the genomic region encompassing the full coding sequence of the PMP22 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Approximately 80% of individuals with hereditary neuropathy with liability to pressure palsies (HNPP) have a 1.5Mb deletion at 17p11.2 (which includes PMP22) on one chromosome (PMID: 8894410, 20301566). Because deletions of PMP22 are a known mechanism of disease in HNPP, this sequence change has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2025

Modify your search Search (all fields optional) Clear all
Advanced Search